• Myelodysplastic Syndromes
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Chronic Lymphocytic Leukemia

Dr. Warlick’s clinical and research efforts focus on the treatment of hematologic malignancies. She has particular interest in myeloid malignancies and the development of new strategies utilizing hematopoietic stem cell transplantation, traditional chemotherapeutics, as well as novel biologic modifiers to treat this diverse group of diseases.